Obesity treatments the new $40b pharma frontier
The drugs’ high cost – Wegovy costs $US1350 a month – and lack of insurance coverage for obesity medicines present a key barrier to uptake. “Outdated notions and persisting misconceptions” about the nature and seriousness of obesity stand…